Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.0090
+0.0074
+(462.50%)
At close: February 26 at 1:27:01 PM EST
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
32,406
37,954
74,789
112,885
Total Liabilities Net Minority Interest
29,015
27,942
32,908
43,333
Total Equity Gross Minority Interest
3,391
10,012
41,881
69,552
Total Capitalization
3,391
10,012
41,881
71,975
Common Stock Equity
3,391
10,012
41,881
69,552
Capital Lease Obligations
1,597
2,028
2,599
1,006
Net Tangible Assets
-21,859
-18,296
-5,871
-23,220
Working Capital
1,383
4,920
18,568
11,987
Invested Capital
3,624
10,264
42,175
72,327
Tangible Book Value
-21,859
-18,296
-5,871
-23,220
Total Debt
1,830
2,280
2,893
3,781
Share Issued
333.1430
42.9000
31.4090
18.8010
Ordinary Shares Number
333.1430
42.9000
31.4090
18.8010
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
OMGAQ
0.0309
-0.38%
NAVB Navidea Biopharmaceuticals, Inc.
0.0009
0.00%
DBVT DBV Technologies S.A.
4.3400
+2.60%
NBY NovaBay Pharmaceuticals, Inc.
0.5900
-3.29%
EPIX ESSA Pharma Inc.
1.6800
0.00%
COEP Coeptis Therapeutics Holdings, Inc.
10.46
-0.85%
VIRX Viracta Therapeutics, Inc.
0.0230
+5.02%
DRMA Dermata Therapeutics, Inc.
1.1400
-1.72%
VINC Vincerx Pharma, Inc.
1.0900
-13.49%
TECX Tectonic Therapeutic, Inc.
25.28
-1.13%